AAAAAA

   
Results: 1-8 |
Results: 8
SAFETY AND IMMUNOGENICITY OF REMUNE(TM) IN HIV-INFECTED THAI SUBJECTS
Authors: LIMSUWAN A CHURDBOONCHART V MOSS RB SIRAWARAPORN W SUTTHENT R SMUTHARAKS B GLIDDEN D TRAUGER R THEOFAN G CARLO D
Citation: A. Limsuwan et al., SAFETY AND IMMUNOGENICITY OF REMUNE(TM) IN HIV-INFECTED THAI SUBJECTS, Vaccine, 16(2-3), 1998, pp. 142-149
PRECLINICAL AND CLINICAL-EXPERIENCE OF INTERLEUKIN-2 (IL-2) AND TGF-BETA ANTISENSE GENE-THERAPY
Authors: SOBOL RE SHAWLER D CARSON C GARRETT M VANBEVEREN C MERCOLA D SMITH L BARTHOLOMEW R BROSTOFF S DORIGO O GOLD D CARLO D ROYSTON I FAHKRAI H
Citation: Re. Sobol et al., PRECLINICAL AND CLINICAL-EXPERIENCE OF INTERLEUKIN-2 (IL-2) AND TGF-BETA ANTISENSE GENE-THERAPY, Cancer gene therapy, 4(1), 1997, pp. 69-69
RESULTS OF PHASE-II RHEUMATOID-ARTHRITIS CLINICAL-TRIAL USING T-CELL RECEPTOR PEPTIDES
Authors: MORELAND L KOOPMAN WJ ADAMSON T CALABRESE L CASH J MARKENSON J MATSUMOTO A MATTESON E WAYAND C CARLO D MORGAN E NARDO C RICHIERI S BROSTOFF S
Citation: L. Moreland et al., RESULTS OF PHASE-II RHEUMATOID-ARTHRITIS CLINICAL-TRIAL USING T-CELL RECEPTOR PEPTIDES, Arthritis and rheumatism, 40(9), 1997, pp. 1156-1156
SEGREGATION OF ADJUVANTS BY THE RELATIVE LEVELS OF GAMMA-IFN TO IL-4 IN THE DRAINING LYMPH-NODE T-CELLS
Authors: CHANG J DIVELEY J LAXER J CARLO D BROSTOFF S WILSON C FENG L
Citation: J. Chang et al., SEGREGATION OF ADJUVANTS BY THE RELATIVE LEVELS OF GAMMA-IFN TO IL-4 IN THE DRAINING LYMPH-NODE T-CELLS, The FASEB journal, 9(3), 1995, pp. 532-532
HIV-1 IMMUNOGEN CLINICAL DEVELOPMENT PLAN
Authors: MOSS RB JENSEN F FERRE F TRAUGER R DAIGLE A RICHIERI S CARLO D
Citation: Rb. Moss et al., HIV-1 IMMUNOGEN CLINICAL DEVELOPMENT PLAN, AIDS research and human retroviruses, 11, 1995, pp. 158-158
CD8-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTORS V-BETA-3 AND( T)OR V-BETA-13.1 GENES/
Authors: CHANG J SMITH L FRONING K SCHWABE B LAXER J CARALLI L KURLAND H KARASEK M WILKINSON D CARLO D BROSTOFF S
Citation: J. Chang et al., CD8-CELLS IN PSORIATIC LESIONS PREFERENTIALLY USE T-CELL RECEPTORS V-BETA-3 AND( T)OR V-BETA-13.1 GENES/, The FASEB journal, 8(4), 1994, pp. 10000205-10000205
SEROLOGICAL AND CELL-MEDIATED IMMUNE-RESPONSE AFTER IMMUNIZATION WITHAN ENVELOPE DEPLETED INACTIVATED HIV-1 IMMUNOGEN - RESULTS OF A 1 YEAR DOUBLE-BLIND ADJUVANT CONTROLLED TRIAL
Authors: TRAUGER RJ GIERMAKOWSKA W COX J LUCAS M JENSEN F CARLO D
Citation: Rj. Trauger et al., SEROLOGICAL AND CELL-MEDIATED IMMUNE-RESPONSE AFTER IMMUNIZATION WITHAN ENVELOPE DEPLETED INACTIVATED HIV-1 IMMUNOGEN - RESULTS OF A 1 YEAR DOUBLE-BLIND ADJUVANT CONTROLLED TRIAL, AIDS research and human retroviruses, 10, 1994, pp. 190000159-190000159
MULTIPLE-SCLEROSIS - T-CELL RECEPTOR (TCR) V-BETA REPERTOIRE EXPRESSION IN IL-2 RECEPTOR-POSITIVE CSF CELLS
Authors: SMITH L BAUMHEFNER RW MALO M CARDENAS G BROSTOFF S CARLO D VANDENNOORT S TOURTELLOTTE WW
Citation: L. Smith et al., MULTIPLE-SCLEROSIS - T-CELL RECEPTOR (TCR) V-BETA REPERTOIRE EXPRESSION IN IL-2 RECEPTOR-POSITIVE CSF CELLS, Neurology, 43(4), 1993, pp. 393-393
Risultati: 1-8 |